Global Diabetic Retinopathy Market Share

Statistics for the 2023 & 2024 Global Diabetic Retinopathy market share, created by Mordor Intelligence™ Industry Reports. Global Diabetic Retinopathy share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Diabetic Retinopathy Industry

The Diabetic Retinopathy market is moderately competitive and consists of a few major players. Companies like Alimera Sciences, Allergan plc, BCN Peptides, F. Hoffmann-La Roche Ltd, Glycadia Pharmaceuticals, Kowa Group, Novartis AG, and Oxurion NV. The players are adopting strategies such as partnerships and acquisitions, product launches, research and development activities, and rising investments to strengthen their presence in the market.

Diabetic Retinopathy Market Leaders

  1. Regeneron Pharmaceuticals, Inc.

  2. Alimera Sciences

  3. Oxurion NV.

  4. Abbvie Inc.

  5. F. Hoffmann-La Roche Ltd

*Disclaimer: Major Players sorted in no particular order

Diabetic Retinopathy Market Concentration

Diabetic Retinopathy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)